Free Trial

Charles River Laboratories International (CRL) Earnings Date, Estimates & Call Transcripts

Charles River Laboratories International logo
$162.48 +0.23 (+0.14%)
As of 01:22 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Charles River Laboratories International Latest Earnings Summary

Upcoming Q1
Earnings Date
May. 8Before Market OpensEstimated
Actual EPS
(Feb. 19)
$2.66 Beat By $0.16
Consensus EPS
(Feb. 19)
$2.50

Charles River Laboratories International issued Q4 2024 earnings on February 19, 2025, reporting an EPS of $2.66, which beat the consensus estimate of $2.50 by $0.16. Quarterly revenue fell 1.1% year-over-year to $1 billion, above analysts' expectations of $983.63 million. With a trailing EPS of $0.15 and a P/E Ratio of 1,082.19, Charles River Laboratories International's earnings are expected to grow 17.43% next year, from $9.41 to $11.05 per share.

CRL Upcoming Earnings

Charles River Laboratories International's next earnings date is estimated for Thursday, May 8, 2025, based off prior year's reporting schedules.

Get Charles River Laboratories International Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Charles River Laboratories International and other key companies, straight to your inbox.

Sign Up
Skip Charts & View Estimated and Actual Earnings Data

CRL Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

CRL Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Charles River Laboratories International Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany Guidance
Q1 20252$2.35$2.41$2.38 
Q2 20252$2.40$2.44$2.42 
Q3 20252$2.59$3.21$2.90 
Q4 20252$2.62$2.85$2.74 
FY 20258$9.96$10.91$10.44 
Q1 20262$2.43$2.75$2.59 
Q2 20262$2.60$2.88$2.74 
Q3 20262$2.63$2.87$2.75 

Charles River Laboratories International Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
5/8/2025
(Estimated)
-------
2/19/2025Q4 2024$2.50$2.66+$0.16-$4.22$983.63M$1.00B
11/6/2024Q3 2024$2.43$2.59+$0.16$3.85$975.99M$1.01B
8/7/2024Q2 2024$2.39$2.80+$0.41$3.86$1.03B$1.03B
5/9/2024Q1 2024$2.05$2.27+$0.22$3.24$997.24M$1.01B
2/14/2024Q4 2023$2.39$2.46+$0.07$1.30$991.25M$1.01B
11/8/2023Q3 2023$2.35$2.72+$0.37$3.75$1.00B$1.03B
8/9/2023Q2 2023$2.63$2.69+$0.06$3.49$1.05B$1.06B
5/11/2023Q1 2023$2.59$2.78+$0.19$3.55$988.10M$1.03B
2/22/2023Q4 2022$2.75$2.98+$0.23$2.31$1.04B$1.10B

Charles River Laboratories International Earnings - Frequently Asked Questions

Charles River Laboratories International has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, May 8th, 2025 based off last year's report dates. Learn more on CRL's earnings history.

Charles River Laboratories International updated its FY25 earnings guidance on Wednesday, February, 19th. The company provided EPS guidance of $9.10-$9.60 for the period, compared to the consensus EPS estimate of $9.60. The company issued revenue guidance of $3.77-$3.87 billion, compared to the consensus revenue estimate of $3.87 billion.

In the previous quarter, Charles River Laboratories International (NYSE:CRL) reported $2.66 earnings per share (EPS) to beat the analysts' consensus estimate of $2.50 by $0.16. Learn more on analysts' earnings estimate vs. CRL's actual earnings.

The conference call for Charles River Laboratories International's latest earnings report can be listened to online.
Listen to Conference Call

The conference call transcript for Charles River Laboratories International's latest earnings report can be read online.
Read Transcript

Charles River Laboratories International's earnings report can be found in their filing with the SEC.
View SEC filing

Charles River Laboratories International (NYSE:CRL) has a recorded annual revenue of $4.05 billion.

Charles River Laboratories International (NYSE:CRL) has a recorded net income of $474.62 million. CRL has generated $0.15 earnings per share over the last four quarters.

Charles River Laboratories International (NYSE:CRL) has a trailing price-to-earnings ratio of 1,086.95 and a forward price-to-earnings ratio of 17.36. The price/earnings-to-growth ratio is 6.77.

Charles River Laboratories International's earnings are expected to grow from $9.41 per share to $11.05 per share in the next year, which is a 17.43% increase.

More Earnings Resources from MarketBeat



This page (NYSE:CRL) was last updated on 2/21/2025 by MarketBeat.com Staff
From Our Partners